Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 30/100

Failure Rate

11.1%

1 terminated/withdrawn out of 9 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

22%

2 trials in Phase 3/4

Results Transparency

100%

2 of 2 completed trials have results

Key Signals

2 recruiting2 with results

Enrollment Performance

Analytics

N/A

4(57.1%)

Phase 3

2(28.6%)

Early Phase 1

1(14.3%)

7Total

N/A(4)

Phase 3(2)

Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT07487844Not ApplicableNot Yet Recruiting

Pulsed Electric Field Ablation for Metastatic Breast Cancer

Role: collaborator

NCT06168058Not ApplicableRecruiting

Trial of Ovarian Vein and Pelvic Vein Embolization in Women With Chronic Pelvic Pain and Pelvic Varices

Role: collaborator

NCT07040163Early Phase 1Active Not Recruiting

Evaluation of Ketamine/Midazolam Sedation vs. Fentanyl/Midazolam Sedation for Image-Guided Percutaneous Procedures in Interventional Radiology

Role: collaborator

NCT06083597Enrolling By Invitation

Development of a Patient-reported Outcome Measure for Women With Chronic Pelvic Pain

Role: collaborator

NCT05501262Not ApplicableRecruiting

Comparative Effectiveness of Cryoablation Versus Steroid and Lidocaine Alone for Treatment of Morton's Neuroma

Role: collaborator

NCT02381509Completed

Predicting the Safety and Effectiveness of Inferior Vena Cava Filters

Role: collaborator

NCT04807010Phase 3Not Yet Recruiting

PROARTE -PROstate ARTery to Reduce the Symptoms of Benign Prostatic Hyperplasia

Role: lead

NCT02173522Not ApplicableTerminated

Phase II Investigation of Prostate Artery Embolization (PAE) Before Radical Prostatectomy in Prostate Cancer Patients

Role: collaborator

NCT00790335Phase 3Completed

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Role: collaborator

All 9 trials loaded